Apellis Pharmaceuticals, Inc. Quarterly Unrecognized Tax Benefits in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Apellis Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q1 2021 to Q2 2024.
  • Apellis Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending June 30, 2024 was $0.000.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $0 $0 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $0 Mar 31, 2024 10-Q 2024-05-07
Q3 2023 $0 -$1.9M -100% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $0 -$1.6M -100% Jun 30, 2023 10-Q 2023-07-31
Q3 2022 $1.9M +$1.9M Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $1.6M +$1.6M Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $1.2M +$1.2M Mar 31, 2022 10-Q 2022-05-04
Q3 2021 $0 Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $0 Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $0 Mar 31, 2021 10-Q 2021-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.